Crescent Biopharma, Inc. (CBIO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -8.94M | -26.74M | -17.52M | -22.16M | -5.11M | -6.27M | 19.4M | -8.89M | -10.51M | -7.61M | -8.68M | -6.97M |
| Operating CF Margin % | -860.15% | -246.59% | - | - | - | - | - | - | - | -76149.97% | - | - |
| Operating CF Growth % | -75.03% | -326.54% | -190.32% | -149.19% | 51.41% | 17.68% | 323.45% | -27.51% | 9.46% | 3.75% | -0.77% | 57.03% |
| Net Income | -23.28M | 22.77M | -24.61M | -21.79M | -2.34M | -37.88M | -2.63M | -10.1M | -10.74M | -9.08M | -9.2M | -8.26M |
| Depreciation & Amortization | 64K | 649K | 0 | 2K | 0 | 35.14M | 0 | 12.42K | 14.62K | 23.3K | 269.94K | 265.87K |
| Stock-Based Compensation | 4.11M | 7.31M | 0 | 0 | 405.43K | 1.16M | 0 | 1.25M | 1.23M | 0 | 0 | 0 |
| Deferred Taxes | 0 | -831K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 10.17M | -37.41M | 2.11M | -4.43M | 0 | -7.08M | 19.06M | 174.05K | 169.57K | 1.14M | 887.84K | 858.09K |
| Working Capital Changes | 0 | -19.24M | 4.97M | 4.06M | -3.17M | 2.39M | 2.98M | -231.14K | -1.18M | 299.87K | -638.45K | 160.1K |
| Change in Receivables | 18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2.31M | 1.02M | 1.49M | -206.37K | -224.63K | -252.49K | 1.48M | 195.23K | -112.58K | 538.23K | 88.4K | -238.66K |
| Cash from Investing | -8.15M | -72.19M | -586K | -140K | 0 | 30K | 9.97K | -2.53K | -7.44K | -801 | -7.87K | -10.53K |
| Capital Expenditures | -147K | -82K | -586K | -140K | 0 | 0 | 9.97K | -2.53K | -7.44K | -801 | -7.87K | -10.53K |
| CapEx % of Revenue | 14.15% | 0.76% | - | - | - | - | - | - | - | 8.01% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -8M | -74.33M | 0 | 0 | 0 | 30K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -6.95M | 178.86M | -1.27M | 145.39M | 0 | 41.03M | -5.4K | 500 | 4.9K | 999 | 61.62K | 20.11K |
| Debt Issued (Net) | 0 | 0 | -14K | 14K | 0 | 37.48M | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 179.04M | -1.43M | -172K | 0 | 4.32M | -5.4K | 500 | 4.9K | 999 | 61.62K | 20.11K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -177K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -6.95M | -177K | 177K | 145.55M | 0 | -760K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -24.03M | 79.93M | -19.38M | 147.03M | -5.11M | 34.77M | -22.39M | -8.9M | -10.51M | -7.61M | -8.63M | -6.97M |
| Free Cash Flow | -9.08M | 22.13M | -18.11M | -22.3M | -5.11M | -3.7M | 19.41M | -8.9M | -10.52M | -7.62M | -8.69M | -6.99M |
| FCF Margin % | -874.3% | 204.1% | - | - | - | - | - | - | - | -76158% | - | - |
| FCF Growth % | -77.91% | 697.95% | -193.3% | -150.69% | 51.45% | 51.4% | 323.36% | -27.35% | 9.41% | 3.74% | -0.83% | 57.07% |
| FCF per Share | -0.30 | 1.10 | -1.09 | -5.78 | -0.26 | -0.19 | 0.30 | -0.14 | -0.16 | -0.12 | -0.14 | -0.11 |
| FCF Conversion (FCF/Net Income) | 0.38x | 0.29x | 0.71x | 1.02x | 0.34x | 0.35x | -1.97x | 0.88x | 0.98x | 0.84x | 0.94x | 0.84x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |